(ACTUALITÉ EN BREF) Aviva Capital Partners (ACP) investit 20 millions de livres sterling dans TopHat, une entreprise qui fabrique des maisons modulaires à faible émission de carbone en utilisant des méthodes de construction modernes (MMC). Le financement par actions soutiendra … Read the full press release
Posted in Business, Construction, Energy, Gas & Oil, Environment, Financial, Industrial, Investment, Technology, United Kingdom
Tagged ACP, Aviva, Aviva Capital Partners, FHS, Future Homes Standard, John Cummins, Jordan Rosenhaus, logements modulaires, maisons à très faible émission de carbone, maisons modulaires à faible émission de carbone, méthodes de construction modernes, MMC, TopHat
(IN BRIEF) Aviva Capital Partners (ACP) is investing £20 million into TopHat, a business that manufactures low carbon modular homes using Modern Methods of Construction (MMC). The equity funding will support TopHat’s new factory in Corby, capable of manufacturing 4,000 … Read the full press release
Posted in Business, Construction, Energy, Gas & Oil, Environment, Financial, Industrial, Investment, Technology, United Kingdom
Tagged ACP, Aviva, Aviva Capital Partners, FHS, Future Homes Standard, John Cummins, Jordan Rosenhaus, low carbon modular homes, MMC, Modern Methods of Construction, modular housing, TopHat, ultra-low carbon homes
(IN BRIEF) Insurance company Aviva has partnered with property developer Stories to invest £100m in UK real estate and infrastructure projects. The venture will mark the first funding commitment from Aviva Capital Partners, Aviva’s new in-house capital unit which develops … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
